Literature DB >> 26883714

Antibiotic Resistance among Urinary Isolates from Female Outpatients in the United States in 2003 and 2012.

Guillermo V Sanchez1, Ahmed Babiker2, Ronald N Master3, Tony Luu4, Anisha Mathur2, Jose Bordon5.   

Abstract

A retrospective analysis was performed using The Surveillance Network, USA, to examine the prevalence of antibiotic resistance among urine isolates from U.S. female outpatients in 2012 and assessed trends in antibiotic resistance comparing data from 2003 and 2012. The most common pathogen identified in 2012 (n = 285,325) was Escherichia coli (64.9% of isolates). In 2012, E. coli resistance to nitrofurantoin was low (<3%) across all age groups. E. coli resistance to ciprofloxacin was high among adults (11.8%) and elderly outpatients (29.1%). When comparing the 2003 and 2012 data from isolates from adults, E. coli resistance to nitrofurantoin changed only slightly (from 0.7% to 0.9%), whereas increases in resistance to ciprofloxacin (3.6% to 11.8%) and trimethoprim-sulfamethoxazole (17.2% to 22.2%) changed substantially. In the United States, E. coli has become increasingly resistant to ciprofloxacin and trimethoprim-sulfamethoxazole (TMP-SMX) in adult female outpatients. Nitrofurantoin retains high levels of antibiotic activity against urinary E. coli.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26883714      PMCID: PMC4862481          DOI: 10.1128/AAC.02897-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

Review 1.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

Authors:  Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

2.  Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection.

Authors:  Kevin A Brown; Nagham Khanafer; Nick Daneman; David N Fisman
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

Review 3.  Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis.

Authors:  Céire Costelloe; Chris Metcalfe; Andrew Lovering; David Mant; Alastair D Hay
Journal:  BMJ       Date:  2010-05-18

4.  Beyond antibiotic selection: concordance with the IDSA guidelines for uncomplicated urinary tract infections.

Authors:  M Kim; A Lloyd; M Condren; M J Miller
Journal:  Infection       Date:  2014-07-18       Impact factor: 3.553

5.  Current antibiotic therapy for isolated urinary tract infections in women.

Authors:  Alexander J Kallen; H Gilbert Welch; Brenda E Sirovich
Journal:  Arch Intern Med       Date:  2006-03-27

6.  Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09.

Authors:  Daniel J Shapiro; Lauri A Hicks; Andrew T Pavia; Adam L Hersh
Journal:  J Antimicrob Chemother       Date:  2013-07-25       Impact factor: 5.790

Review 7.  The epidemiology of urinary tract infection.

Authors:  Betsy Foxman
Journal:  Nat Rev Urol       Date:  2010-12       Impact factor: 14.432

Review 8.  Urinary tract infections in older women: a clinical review.

Authors:  Lona Mody; Manisha Juthani-Mehta
Journal:  JAMA       Date:  2014-02-26       Impact factor: 56.272

Review 9.  Urinary tract infection at the age extremes: pediatrics and geriatrics.

Authors:  Linda M Dairiki Shortliffe; Jack D McCue
Journal:  Am J Med       Date:  2002-07-08       Impact factor: 4.965

Review 10.  Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success.

Authors:  Liam S Redgrave; Sam B Sutton; Mark A Webber; Laura J V Piddock
Journal:  Trends Microbiol       Date:  2014-05-16       Impact factor: 17.079

View more
  48 in total

1.  A Systematic Review of Single-Dose Aminoglycoside Therapy for Urinary Tract Infection: Is It Time To Resurrect an Old Strategy?

Authors:  Kellie J Goodlet; Fatima Z Benhalima; Michael D Nailor
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

2.  Geographic Mapping of Escherichia coli Susceptibility To Develop a Novel Clinical Decision Support Tool.

Authors:  Laurel Legenza; Susanne Barnett; James P Lacy; Codie See; Natalee Desotell; Andrea Eibergen; Jeffrey F Piccirillo; Warren E Rose
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

3.  Antimicrobial Resistance of Escherichia coli Urinary Isolates in the Veterans Affairs Health Care System.

Authors:  Haley J Morrill; Jacob B Morton; Aisling R Caffrey; Lan Jiang; David Dosa; Leonard A Mermel; Kerry L LaPlante
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

4.  Reply to "Nitrofurantoin, an Excellent Empiric Choice for Outpatient Cystitis".

Authors:  Ahmed Babiker; Guillermo V Sanchez; Siddartha Bhandary; Jose M Bordon
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

5.  Nitrofurantoin, an Excellent Empiric Choice for Outpatient Cystitis.

Authors:  Nicolas W Cortes-Penfield; Barbara W Trautner
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

6.  Acidosis induces antimicrobial peptide expression and resistance to uropathogenic E. coli infection in kidney collecting duct cells via HIF-1α.

Authors:  Hu Peng; Jeffrey M Purkerson; Robert S Freeman; Andrew L Schwaderer; George J Schwartz
Journal:  Am J Physiol Renal Physiol       Date:  2019-12-16

Review 7.  Lack of uniformity among United States recommendations for diagnosis and management of acute, uncomplicated cystitis.

Authors:  Melissa A Markowitz; Lauren N Wood; Shlomo Raz; Loren G Miller; David A Haake; Ja-Hong Kim
Journal:  Int Urogynecol J       Date:  2018-08-11       Impact factor: 2.894

Review 8.  New and developing diagnostic technologies for urinary tract infections.

Authors:  Michael Davenport; Kathleen E Mach; Linda M Dairiki Shortliffe; Niaz Banaei; Tza-Huei Wang; Joseph C Liao
Journal:  Nat Rev Urol       Date:  2017-03-01       Impact factor: 14.432

9.  Opportunities to Improve Fluoroquinolone Prescribing in the United States for Adult Ambulatory Care Visits.

Authors:  Sarah Kabbani; Adam L Hersh; Daniel J Shapiro; Katherine E Fleming-Dutra; Andrew T Pavia; Lauri A Hicks
Journal:  Clin Infect Dis       Date:  2018-06-18       Impact factor: 9.079

Review 10.  Urinary Tract Infection and Asymptomatic Bacteriuria in Older Adults.

Authors:  Nicolas W Cortes-Penfield; Barbara W Trautner; Robin L P Jump
Journal:  Infect Dis Clin North Am       Date:  2017-12       Impact factor: 5.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.